Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$48M |
| 2 |
American Electric Power
AEP
|
+$40.9M |
| 3 |
Comcast
CMCSA
|
+$38.2M |
| 4 |
Entergy
ETR
|
+$30.6M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$378M |
| 2 |
Amazon
AMZN
|
+$336M |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Alibaba
BABA
|
+$258M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.92% |
| 2 | Consumer Discretionary | 8.02% |
| 3 | Utilities | 7.46% |
| 4 | Healthcare | 7.42% |
| 5 | Financials | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Compañía de Minas Buenaventura
BVN
$8.94B
| $572K | 0.01% |
+57,077
| New | +$620K |
|
|
HGEN
1252
DELISTED
HUMANIGEN, INC.
HGEN
| $572K | 0.01% |
29,964
-95,649
| -76% | -$1.75M |
|
1253
Aterian
ATER
$7.96M
| $571K | 0.01% |
+1,612
| New | +$621K |
|
1254
BlackLine
BL
$1.86B
| $570K | 0.01% |
+5,255
| New | +$655K |
|
1255
Veritone
VERI
$86M
| $569K | 0.01% |
+23,719
| New | +$846K |
|
1256
Middleby
MIDD
$5.21B
| $567K | 0.01% |
+3,418
| New | +$503K |
|
1257
Annaly Capital Management
NLY
$17.5B
| $567K | 0.01% |
+16,493
| New | +$559K |
|
|
ROCC
1258
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $566K | 0.01% |
+42,223
| New | +$580K |
|
|
AERI
1259
DELISTED
Aerie Pharmaceuticals
AERI
| $564K | 0.01% |
+31,559
| New | +$545K |
|
1260
Rapid7
RPD
$822M
| $563K | 0.01% |
+7,542
| New | +$627K |
|
|
KAMN
1261
DELISTED
Kaman Corp
KAMN
| $563K | 0.01% |
+10,974
| New | +$597K |
|
|
MSGN
1262
DELISTED
MSG Networks Inc.
MSGN
| $563K | 0.01% |
+37,414
| New | +$626K |
|
1263
ProPetro Holding
PUMP
$1.33B
| $562K | 0.01% |
52,684
-128,101
| -71% | -$1.27M |
|
1264
Commercial Metals
CMC
$7.18B
| $561K | 0.01% |
+18,203
| New | +$451K |
|
1265
Immersion
IMMR
$250M
| $561K | 0.01% |
+58,534
| New | +$696K |
|
1266
Bruker
BRKR
$8.68B
| $559K | 0.01% |
8,702
-85,452
| -91% | -$5.13M |
|
1267
MakeMyTrip
MMYT
$5.67B
| $559K | 0.01% |
+17,686
| New | +$562K |
|
|
VIRX
1268
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $559K | 0.01% |
+60,443
| New | +$630K |
|
1269
Loews
L
$22.8B
| $558K | 0.01% |
10,878
+1,486
| +16% | +$72.4K |
|
1270
Virtus Investment Partners
VRTS
$1.13B
| $556K | 0.01% |
2,362
+1,355
| +135% | +$326K |
|
1271
WesBanco
WSBC
$3.91B
| $556K | 0.01% |
15,429
-10,223
| -40% | -$336K |
|
1272
Belden
BDC
$4.56B
| $555K | 0.01% |
+12,516
| New | +$569K |
|
1273
World Acceptance Corp
WRLD
$887M
| $555K | 0.01% |
4,280
-4,157
| -49% | -$547K |
|
|
RAPT
1274
DELISTED
RAPT Therapeutics
RAPT
| $554K | 0.01% |
3,119
-106
| -3% | -$17.5K |
|
1275
Sun Communities
SUI
$15B
| $554K | 0.01% |
3,692
-17,934
| -83% | -$2.65M |
|
Similar funds
Michael Gelband's Q1 2021 Portfolio in Review
As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.
Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.
- Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
- Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
- Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
- Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
- Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
- Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
- Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.